Riverbridge Partners LLC increased its position in shares of Orthopediatrics Corp (NASDAQ:KIDS) by 46.0% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 749,104 shares of the company’s stock after purchasing an additional 236,034 shares during the quarter. Riverbridge Partners LLC’s holdings in Orthopediatrics were worth $35,200,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in the stock. Massachusetts Financial Services Co. MA boosted its position in Orthopediatrics by 62.4% in the third quarter. Massachusetts Financial Services Co. MA now owns 671,588 shares of the company’s stock valued at $23,680,000 after buying an additional 258,146 shares in the last quarter. BlackRock Inc. grew its stake in Orthopediatrics by 16.8% during the second quarter. BlackRock Inc. now owns 585,555 shares of the company’s stock worth $22,837,000 after buying an additional 84,205 shares during the last quarter. Russell Investments Group Ltd. acquired a new stake in shares of Orthopediatrics during the second quarter worth approximately $2,055,000. United Services Automobile Association raised its stake in shares of Orthopediatrics by 85.6% in the second quarter. United Services Automobile Association now owns 73,219 shares of the company’s stock valued at $2,856,000 after acquiring an additional 33,770 shares during the last quarter. Finally, Roubaix Capital LLC raised its stake in shares of Orthopediatrics by 35.5% in the third quarter. Roubaix Capital LLC now owns 121,501 shares of the company’s stock valued at $4,284,000 after acquiring an additional 31,845 shares during the last quarter. 44.86% of the stock is owned by hedge funds and other institutional investors.

A number of equities research analysts recently weighed in on the company. BidaskClub raised Orthopediatrics from a “buy” rating to a “strong-buy” rating in a report on Wednesday, January 1st. SunTrust Banks assumed coverage on Orthopediatrics in a research note on Tuesday, January 7th. They issued a “buy” rating and a $54.00 price objective on the stock. Zacks Investment Research lowered Orthopediatrics from a “strong-buy” rating to a “hold” rating in a research note on Thursday, January 9th. ValuEngine cut Orthopediatrics from a “hold” rating to a “sell” rating in a report on Friday. Finally, Piper Jaffray Companies raised their target price on Orthopediatrics from $44.00 to $50.00 and gave the company an “overweight” rating in a research note on Monday, December 16th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company. The stock currently has an average rating of “Buy” and an average target price of $49.83.

In other news, CEO Mark C. Throdahl sold 10,000 shares of the business’s stock in a transaction on Friday, December 13th. The stock was sold at an average price of $34.31, for a total transaction of $343,100.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP David R. Bailey sold 15,000 shares of the company’s stock in a transaction on Friday, December 13th. The shares were sold at an average price of $34.31, for a total value of $514,650.00. The disclosure for this sale can be found here. 40.70% of the stock is currently owned by corporate insiders.

Shares of KIDS stock traded down $0.07 during trading hours on Tuesday, reaching $46.82. 125,000 shares of the company were exchanged, compared to its average volume of 126,867. Orthopediatrics Corp has a fifty-two week low of $28.19 and a fifty-two week high of $51.48. The company has a debt-to-equity ratio of 0.24, a current ratio of 2.35 and a quick ratio of 1.61. The stock’s fifty day moving average is $43.46 and its two-hundred day moving average is $37.49. The company has a market cap of $809.21 million, a price-to-earnings ratio of -48.77 and a beta of 0.28.

Orthopediatrics (NASDAQ:KIDS) last issued its quarterly earnings results on Thursday, November 7th. The company reported ($0.18) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.17) by ($0.01). Orthopediatrics had a negative net margin of 15.80% and a negative return on equity of 12.12%. The company had revenue of $20.74 million during the quarter, compared to analyst estimates of $19.87 million. During the same period in the prior year, the business earned ($0.15) EPS. The business’s revenue for the quarter was up 31.1% on a year-over-year basis. On average, research analysts anticipate that Orthopediatrics Corp will post -0.83 earnings per share for the current year.

Orthopediatrics Company Profile

OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company's products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail products, PediLoc tibia products, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, RESPONSE Spine systems, Bandloc, and Pediguard.

Read More: How do investors use RSI to grade stocks?

Want to see what other hedge funds are holding KIDS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Orthopediatrics Corp (NASDAQ:KIDS).

Institutional Ownership by Quarter for Orthopediatrics (NASDAQ:KIDS)

Receive News & Ratings for Orthopediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthopediatrics and related companies with MarketBeat.com's FREE daily email newsletter.